CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to DSKYF

Intrathecal (IT) triple chemotherapy prophylaxis

Phase 2
Daiichi Sankyo (DSKYF)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q2 '27
DSKYFPhase 2

Intrathecal (IT) triple chemotherapy prophylaxis Phase 2 Est. Readout

Intrathecal (IT) triple chemotherapy prophylaxis
Q2 2027~Q
CT.gov
00%
Competitive Landscape
Drug Information

Target Indication

Acute Myeloid Leukemia

Clinical Trial

NCT03793478

Last updated: 8/26/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.